Fortis Healthcare Ltd

Stage 4 · Declining · week 2

As of 9 Oct 2026, Fortis Healthcare is in Stage 4 — declining, a downtrend, in week 2 (since 30 Sep 2026). It closed at ₹786, 28.4% below its 52-week high and below its 200-day average, which is falling. In Health Care, 44.6% of stocks are in Stage 2.

Fortis Healthcare Limited operates as a healthcare delivery service provider in India. More about the company

₹786.3
+3.05% today
₹59,359 Cr · Large cap
Market Neutral — FadingHealth Care 44.6% in Stage 2-2.6 pts / 20dHospitals & Diagnostic Centres 32.3%-6.5 pts

Pro read

Pro

Our read

Declining — below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is FORTIS early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-28.4%
₹763 lo₹1,097.9 hi
28.4% below 52W high — ongoing decline
In Stage 4, distance from the 52W high reflects ongoing decline — not a discount. Avoid catching falling knives.
Stage Maturity
Week 2
1w13w26w
Week 2 — early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure — there's no 'bottom' time to buy.
vs 200 DMA
-13.4%
200 DMA: ₹907.5 · sloping down
In Stage 4, the stock is below its 200 DMA — the hallmark of a downtrend. No long positions warranted until this reverses structurally.
Rel Volume
2.30x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low volume bounces are typical — they lack real buyers and should not be mistaken for reversals.
Trend Health
↓
MA20 rolling over · -6.8% vs MA50 -5.2%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-13.4%
3M
-18.8%
6M
-6.5%
YTD
-12.8%
1Y
-20.6%
Sector
Health Care
↓ Peaking
Stage 2%
44.6%
20d Δ
-2.6pp
1M return
-4.9%
3M return
+0.2%
Sector Stage-2 % · last 20 days
Sector has 74 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
32.3%
20d Δ
-6.5pp
1M return
-8.1%
3M return
-10.8%
Industry Stage-2 % · last 20 days
Industry has 9 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →
Stage Cycle Timeline2023-07-14 → 2026-10-09
S2 36w
S2 41w
S2 32w
2023-07-142026-10-09
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 36w → S3 5w → S2 41w → S3 10w → S2 32w → S3 12w → S2 1w → S1 2w → S4 5w → S1 6w → S2 8w → S3 7w → S4 1w current
Total tracked: 167 weeks across 13 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-06-15
4 appearances in last 60 days. First seen: 2024-04-29.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-09S4
Wk 2 · Vol 2.30x
2026-10-08S4
Wk 2 · Vol 1.06x
2026-10-07S4
Wk 1 · Vol 1.20x
2026-10-06S4
Wk 1 · Vol 0.81x
2026-10-05S4
Wk 1 · Vol 1.40x
2026-10-01S4
Wk 1 · Vol 5.01x
2026-09-30S43→4
Wk 1 · Vol 4.54x
2026-09-29S3
Wk 7 · Vol 2.03x
2026-09-28S3
Wk 7 · Vol 2.17x
2026-09-25S3
Wk 7 · Vol 2.08x
2026-09-24S3
Wk 7 · Vol 0.77x
2026-09-23S3
Wk 6 · Vol 0.84x
Sector Peers — Stage 2All →
BAFNAPH
wk 18 · 0.0% from hi
8.6
ZIMLAB
wk 22 · 0.0% from hi
8.3
KILITCH
wk 2 · -7.3% from hi
8.3
SMSPHARMA
wk 3 · -8.0% from hi
8.3
RPGLIFE
wk 16 · -12.0% from hi
7.6
Moving averages & range
50 DMA
₹888.2
200 DMA
₹907.5
52W High
₹1,097.9
52W Low
₹763
5D Low
₹763
Resistance levels (recent highs)
20d High
₹902.5
60d High
₹969
120d High
₹990.4
250d High
₹1,097.9
Next resistance
+14.8%
to 20d High
Ask the Market AI about FORTISAsk →
P/E (TTM)
69.5
Forward 41.0
Earnings Growth (YoY)
+44.3%
Revenue +17.8%
ROE
+11.0%
Profit margin +11.4%
Dividend Yield
0.10%
P/B 7.3
About this companyHealth Care· Hospitals & Diagnostic Centres

Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company offers services in the areas of cardiac science, critical care, vascular surgery, dental science, dermatology, diabetology/endocrinology, emergency and trauma, geriatric medicine, liver transplant and hepatobiliary sciences, pain and palliative medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, and haematology areas. It also provides services in the areas of infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplant, rheumatology, thoracic surgery, transfusion medicine, urology, medical generics, endocrine surgery, and other support specialties, as well as treat infectious diseases. The company's healthcare verticals comprise hospitals, diagnostics, tertiary and quaternary care, and day care specialty facilities. Fortis Healthcare Limited was incorporated in 1996 and is based in Gurugram, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-09. Past data patterns are not indicative of future results. This page is a data analytics tool only.